ArticleBioengineered2021

Absent in melanoma 1-like (AIM1L) serves as a novel candidate for overall survival in hepatocellular carcinoma.

Wenliang Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.